Business Effectiveness Key Component To Compliance Program, TAP Says
This article was originally published in The Pink Sheet Daily
Ethics & Compliance Officer Stephan Vincze suggests that compliance programs should be considered a financial asset, such as a pre-paid insurance plan. HHS IG suggests that considering business perspectives will encourage long-term adherence to the compliance program.
You may also be interested in...
“We are prepared to enter discussions toward a decree at FDA’s earliest convenience,” Able says in letter to FDA. Company is pursuing consent decree instead of responding to FDA Form 483 report citing manufacturing deficiencies. The letter follows CEO Maury’s resignation the previous day.
QLT now has worldwide marketing rights to the topical acne treatment. Astellas believes labeling proposed by FDA will limit the market profile for Aczone, the company said. Aczone’s user fee deadline is July 7.
Acquisition will enable company to leverage "end-to-end" product development through post-commercialization offerings, company says. Omnicare is now in discussions with NeighborCare after raising its takeover bid to $1.55 bil.